FDA-OVERSIGHT Guidance for Industry - Oversight of Clinical Investigations - A Risk-Based Approach to Monitoring

FDA-OVERSIGHT - 2013 EDITION - CURRENT



Guidance for Industry - Oversight of Clinical Investigations - A Risk-Based Approach to Monitoring


This document comes with our free Notification Service, good for the life of the document.

This document is available in either Paper or PDF format.

ORDER

Price:

$20.00        




Document Number

10555fnl

Revision Level

2013 EDITION

Status

Current

Publication Date

Aug. 2, 2013

Page Count

22 pages